Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM

NCT01912534 is registered in ClinicalTrials.gov with Carelon Research as lead sponsor.

NCT NCT01912534
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT01912534 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Valsartan for Attenuating Disease Evolution In Early Sarcomeric HCM
Lead sponsor
Carelon Research
Phase
Phase 2
Overall status
Completed
Start date
March 31, 2014
Completion date
July 31, 2019
Enrollment
211 (actual)
Sites
15

Conditions

As the registry lists them; a condition with its own page is linked.

hypertrophic cardiomyopathy